NCT06997094 2026-01-26
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Mayo Clinic
Phase 1 Recruiting
Clinical Trials
1 trialsRecruiting × Interventional × Human Papillomavirus-Negative Neck Squamous Cell Carcinoma × Clear all